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Stroke is the second leading cause of death world-
wide, after ischemic heart disease,1 and the most
important cause of long-term disability.2 Eighty-five
percent of strokes are ischemic.3 Of these, two thirds
are of carotid origin and one third are from the heart
or other vessels.4 Fieschi et al5 found that, in con-
scious patients with acute ischemic strokes that neces-
sitated admission to a stroke unit, 76% had angio-
graphic evidence of complete occlusion of the internal
carotid artery, the middle cerebral artery, or one of its
branches. Most of these occlusions were thought to
be embolic and of cerebrovascular origin.5
Carotid endarterectomy was introduced in the
1950s for the prophylaxis of strokes. Reports of
unacceptable complication rates led to the benefits of
this surgical intervention being brought into ques-
tion6 and to the prosecution of randomized con-
trolled trials that assessed the efficacy of the proce-
dure in different clinical settings. We systematically
sought to identify these trials, including subsidiary
publications of subgroup analyses, with the purpose
of providing a meta-analysis of the main results and a
critical summary of the published subgroup analyses.
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Objective: The purpose of this study was to summarize the existing literature on the effi-
cacy of carotid endarterectomy in patients with ipsilateral symptomatic carotid stenosis.
Methods: Database searching, relevance assessment, methodologic quality assessments,
and data extraction were all performed in duplicate with prespecified criteria.
Results: Twenty-three publications were identified from the North American Symptomatic
Carotid Endarterectomy Trial, the European Carotid Surgery Trial, and the Veterans
Affairs Cooperative Studies Program. Stenosis was reported as measured in the North
American Symptomatic Carotid Endarterectomy Trial. In patients with >70% stenosis,
carotid endarterectomy was associated with a pooled relative risk reduction of 48% (95%
confidence interval [CI], 27% to 73%) and an absolute risk reduction of 6.7% (95% CI,
3.2% to 10%) for the outcome of death or major disability from stroke. This translates
into a number needed to treat of 15 (95% CI, 10 to 31). For patients with 50% to 69%
stenosis, the benefit of surgery was less and the confidence intervals were wider. A rela-
tive risk reduction of 27% (95% CI, 5% to 44%), an absolute risk reduction of 4.7% (95%
CI, 0.8% to 8.7%), and a number needed to treat of 21 (95% CI, 11 to 125) were
observed in this group. The patients with the lowest degrees of stenosis (<50%) were
harmed by the intervention (number needed to harm, 45). Increasing degree of stenosis,
increasing age, male sex, the presence of other medical risk factors, and the presence of
hemispheric rather than retinal antecedent events were factors that increased the benefits
from surgery.
Conclusion: Carotid endarterectomy reduced death or major disability from stroke in
patients with >50% symptomatic stenosis. To maximize the benefits of surgery, careful
preoperative risk assessment and the maintenance of low rates of major perioperative
complications are mandatory.  (J Vasc Surg 1999;30:606-17.)
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METHODS
Inclusion and exclusion criteria. Studies were
selected for review if they met the following criteria:
comparison of carotid endarterectomy with nonsur-
gical management, inclusion of patients with carotid
stenosis ipsilateral to neurologic symptoms or signs
in the carotid territory, and randomized controlled
trial design. We excluded studies with unusual tech-
niques of carotid endarterectomy (ie, femorocarotid
shunting during surgery),7 and studies in which
patients who were symptomatic and asymptomatic
or patients with hemispheric and vertebrobasilar
symptoms could not be separated.8
Search strategy. The following search strategy
was conducted (capitals are used to indicate pre-
exploded medical subject headings/coding terms,
and lower case is used to indicate text words):
Medline database (Ovid Technologies, Inc, New
York City, NY) from 1966 to September 1998 with
Ovid software (Ovid Technologies, Inc) and the con-
tent strategy (ENDARTERECTOMY, CAROTID
or [carotid and endarterectomy]) combined with a
previously validated sensitive methodologic filter
strategy for the identification of randomized con-
trolled trials in this database9; the Cochrane Database
of Systematic Reviews, The Database of Abstracts 
of Reviews of Effectiveness, and the Cochrane Con-
trolled Clinical Trials Register (Cochrane Library
1998, Issue 3; The Cochrane Collaboration Software
Ltd, Oxford, United Kingdom), with the same con-
tent strategy; EMBASE (Elsevier Science B.V.,
Amsterdam, The Netherlands) 1990 to May 1997,
with the strategy ([CAROTID ARTERY OB-
STRUCTION or CAROTID ARTERY SURGERY]
and CONTROLLED STUDIES and [random or
random*, with * indicating truncation]); Healthstar
and Serline databases 1966 to May 1997, with
Grateful Med software (National Library of Med-
icine, Bethesda, Md) and the strategy (carotid endar-
terectomy or carotid stenosis); Best Evidence
(American College of Physicians, Philadelphia, Pa)
1991 to 1996 and the search term, carotid; reference
lists of all relevant articles; reference lists of review
articles; and the Cochrane Stroke Group Specialized
Register of Trials (The Cochrane Collaboration
Software LTD).
Having identified the two major studies in this area,
a post hoc search strategy of ECST or the European
Carotid Surgery Trial or NASCET or the North
American Symptomatic Carotid Endarterectomy Trial
(each as text words) was performed in the Medline
database from 1990 to October 1998 and in the
Cochrane Controlled Trials Register 1998, issue 4, in
the hope of the identification of previously unretrieved
publications from these trials.
Relevance and validity. A review of titles and
abstracts identified the studies that might be poten-
tially relevant. These studies were retrieved so that
the final decision of relevance was made on the basis
of the full text. The studies were reviewed in dupli-
cate (C.S.C., C.M.C.) for relevance and for internal
validity (methodologic rigor). The latter was
assessed with a series of prespecified questions (avail-
able on request from the authors).
Data extraction. A standardized form was used
to collate data by both independent reviewers. The
details of study design, patient selection, baseline
characteristics, surgical procedure, cointerventions,
follow-up examinations, and outcome assessment
were recorded.
The method of calculation of percentage stenosis
differed between studies. Two studies have com-
pared actual measurements with the NASCET
methodology10 with those of the ECST methodolo-
gy11 and derived a nomogram12 and a formula13 for
interconversion. The intraclass correlation coeffi-
cient as a measure of agreement between actual
stenosis and that predicted from the conversion for-
mula was reported for one of these studies only13
and was 0.83. Accordingly, we used the formula:
ECST % stenosis = 0.6 (NASCET % stenosis) + 4013
to convert all the reported percentage stenoses to
NASCET equivalents, and, for simplicity, this
NASCET equivalent percentage stenosis was used
consistently in this work, regardless of which study
was being discussed. Table I summarizes the rela-
tionship between the two measurement methods.
Selection of outcomes. In the selection of out-
Table I. Conversion table for different classes of degree of stenosis13
Minimal disease Stenosis Occluded
ECST 0 30% 24% 58% 70% 82% 99% 100%
NASCET -76% -17% 0 30% 50% 70% 99% 100%
ECST, European Carotid Surgery Trial; NASCET, North American Symptomatic Carotid Endarterectomy Trial.
comes for inclusion in this review, we considered the
following: (1) the risk of surgery is an increase in
death and stroke, probably within the first 30 days;
(2) the benefit of surgery is a subsequent reduction
in the risk of nonhemorrhagic ipsilateral stroke; and
(3) hemorrhagic strokes, cardioembolic strokes, and
death from causes other than stroke add variability
(noise) to the experiment. We believed that the out-
come cluster “death or major disability from stroke”
best captured the overall net benefit of therapy.
The outcome that most closely approximated this
in the ECST was “all disabling/fatal stroke or surgical
death.” Disability was defined as a modified Rankin
score of 3 at 6 months. Death from all causes within
the first 30 days was included. In the NASCET, the
similar outcome “any major stroke or death” includes
stroke producing functional deficits (Rankin score of
3 or more) at 90 days and death from any cause 
during the whole follow-up period. No similar out-
come could be identified from the Veterans Affairs
Cooperative Studies Program (VACSP), in which the
primary analysis was of the cluster “perioperative
death, ipsilateral stroke or ipsilateral stroke or ipsilat-
eral crescendo TIA [transient ischemic attack].”
For subgroup analyses, we were limited to the
outcomes reported by the original authors, which in
some instances did not include the primary out-
comes indicated previously.
Meta-analysis. Analysis was performed with
Review Manager 3.1 software, Cochrane Collabor-
ation (The Cochrane Collaboration Software Ltd),
1998. Fixed effects models were used to estimate
pooled relative and absolute risk reductions and 95%
confidence interval (CI).14 The sensitivity of results
to the statistical method was assessed with the exam-
ination also of the random effects model (Der
Simonian and Laird).14 Log-linear analysis of the
lacunar stroke data was performed with BMDP
Statistical Software 7.0 (BMDP Statistical Software,
Inc, Los Angeles, Calif).
RESULTS
Search results. Twenty-three relevant publi-
cations from three randomized studies were iden-
tified: the NASCET,10,15-28 the ECST,29-32 and
the VACSP.33,34 Overall, 6078 patients have been
randomized (3777 to surgery, 2301 to medical
treatment).
Two randomized studies of carotid endarterecto-
my did not meet inclusion criteria. The first is The
Joint Study of Extracranial Arterial Disease.35-38
This study included not only carotid endarterectomy
but also surgery of the aortic arch branches and ver-
tebral arteries in patients who were symptomatic and
in a few patients who were asymptomatic. A sub-
group analysis of patients with unilateral carotid 
disease who underwent carotid endarterectomy39
included 54% of patients with vertebrobasilar symp-
toms. The second trial7 reported on carotid
endarterectomy with the unusual adjunct of femoro-
carotid bypass grafting and was stopped early
because of high postoperative morbidity.
Relevance and validity. Interobserver reliability
for judgement of relevance was excellent with Cohen’s
κ statistic 0.93 (95% CI, 0.84 to 1.0). The sensitivity
of the Medline search was 76% and of the EMBASE
search was 52%. Of the 23 relevant articles, five were
identified with EMBASE alone, 10 with Medline
alone, and six from both searches. No publication was
judged relevant that had not been identified in one or
another of these two database searches.
The interobserver agreement for decisions relat-
ed to methodologic quality was good with a weight-
ed Cohen’s κ statistic of 0.75. For the data extrac-
tion, there was an error rate of 1.2% and a rate of
minor disagreement of 1.6%. All disagreements were
resolved by consensus.
Patient characteristics. Each of the studies ran-
domized only patients who had had a recent neuro-
logical event in the territory of a stenosed carotid
artery. The qualifying events were nondisabling
strokes and TIAs and were variously but sensibly
defined (Table II).
All the studies dealt with a predominantly male,
elderly population. The patients who were at highest
operative risk were excluded from all three studies.
All three studies used explicit exclusion criteria, and
the ECST, in addition, used the “uncertainty princi-
ple,” which refers to the state of equipoise relating
to the intervention: if the patient’s physician
believed that the patient would clearly benefit, or
clearly not benefit, from the surgery, the patient was
excluded. The exclusion criteria in common
between the studies were: severe coexisting medical
disease, possible cardiac causes of emboli, major
stroke, coexisting internal carotid artery stenosis
beyond C2 (tandem lesions), and prior ipsilateral
carotid endarterectomy.
Comorbidity in the form of ischemic heart dis-
ease, diabetes, hypertension, hypercholesterolemia,
and smoking was well represented among the patients
(Table II).
Methodologic quality. A summary of the
reviewers’ assessment of quality issues in both the
conduct of the studies and their reporting is provid-
ed in Table III. Because of the nature of the inter-
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vention, none of these randomized controlled trials
could be blinded for surgeons or patients.
The intervention itself was left to the discretion
of the surgeon in each study. NASCET reported the
frequency of different surgical techniques (use of
patch and use of shunt). Remarkably, few patients
were lost to follow-up examination in any of these
studies. Each study made use of an independent
external review process for all outcomes, but the
clinical data presented for review were derived from
unblinded assessment and may therefore have been
subject to bias.
All three randomized controlled trials conducted
an intention-to-treat analysis (Table III). A propor-
tion of patients in each arm after randomization ulti-
mately underwent the treatment of the opposite
assignment. In the case of such surgical-to-medical
crossover, this was usually because the patient
declined surgery after randomization. Medical-to-sur-
gical crossovers occurred in a small proportion of
patients in all the studies. In both NASCET and
VACSP, but not in ECST, patient follow-up data were
censored at the time of medical-to-surgical crossover.
Outcome: death or major diability from stroke.
ECST and NASCET showed a statistically significant
and clinically important improvement in outcome with
surgery in patients with the highest degrees of steno-
sis. The results of the meta-analysis are shown in Fig 1.
The beneficial effect of surgery is most evident in
the range of 70% to 99% stenosis. A meta-analysis 
of the results for “any disabling or fatal stroke or sur-
gical death” at 5 years from ECST31 and for “any
major stroke or death” at 2 years from NASCET10
showed an absolute risk reduction (ARR) of 6.7%
(95% CI, 3.2 to 10) corresponding to a number
needed to treat (NNT) of 15 (95% CI, 10 to 31; Fig
1; Table IV). The benefit of surgery was less evident
in patients with 50% to 69% stenosis. The ARR was
4.7% (95% CI, 0.8 to 8.7), with a corresponding
NNT of 21 (95% CI, 11 to 125).31,40 The follow-up
period in this group of patients was 6 years in ESCT
and 5 years in NASCET. The relative risk reduction
Table II. Patient characteristics10,11,31,40
ECST NASCET VACSP
Duration of trial 1981 to 1995 1987 to 1997 1988 to 1991
Origin of trial Europe and Australia North America United States
No. of centers 97 106 16
Qualifying neurologic event
Hemispheric TIA (%) 38 38
TMB (%) 12 37
Hemispheric stroke (%) 43 24
Retinal infarct (%) 5
Prior neurologic event
TIA (%) 50 55* 60
Stroke (%) 27† 27
Contralateral stenosis >50% (%) 6 9
Contralateral occlusion (%) 4 7
Age (years) 63 66 65
Male sex (%) 72 69 100
MI (%) 24‡ 36‡ 37
Angina (%) 47
Cardiac surgery (%) 19
Diabetes (%) 12 21 30
Hyperlipidaemia (%) 35
Smoking (%) 52 31 92
Hypertension (%) 50 61 47
Peripheral vascular disease (%) 16 16 43
Obesity (%) [BMI, 25] 47
Mean delay, last ischemic event to randomization (days) 52
Median delay, randomization to surgery (days) 12 2
Median (minimum to maximum) delay last ischemic event to surgery (days) 28 (0 to 122)
ECST, European Carotid Surgery Trial; NASCET, North American Symptomatic Carotid Endarterectomy Trial; VACSP, Veterans Affairs
Cooperative Studies Program; TIA, transcient ischemic disease; TMB, transient monocular blindness; MI, myocardial infarction; BMI,
body mass index.
*Includes transient ischemic attack and stroke.
†Disabling strokes.
‡Includes myocardial infarction and angina.
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(RRR) obtained with the combination of the results
in the two studies was 48% for patients with >70%
stenosis and 27% for patients with 50% to 70% steno-
sis. Despite differences in trial design, RRR was
remarkably similar in the two studies for both classes
of degree of stenosis. ECST, with the continuation of
follow-up examination of crossed-over patients and
the analysis of these patients in the group of their ini-
tial assignment, answered the question: in patients
with symptomatic carotid stenosis for whom benefit
was in doubt, does a strategy of “carotid endarterec-
tomy as soon as possible” compared with a strategy
of “avoid surgery if at all possible, for as long as pos-
sible” reduce subsequent stroke? NASCET, in which
patients were censored at crossover, addressed the
question: in patients with symptomatic carotid steno-
sis, does “carotid endarterectomy as soon as possi-
ble” compared with “no carotid endarterectomy”
reduce subsequent stroke?
For patients with <50% stenosis, surgery was
associated with a small absolute risk increase of 2.2%
(95% CI, 0 to 4.4) and a corresponding number
needed to harm of 45 (95% CI, 22 to infinity).
Pooled absolute and relative risk reductions were
not sensitive to whether a random or fixed effects
model was used (with the exception of the absolute
risk increase in the <50% stenosis group, which
changed from borderline significance to nonsignifi-
cance at the conventional 95% level), and no statisti-
cally or clinically significant heterogeneity was
observed. In this analysis of only two studies, the
power to detect such heterogeneity is low.
A “death or disability outcome” was not avail-
able from the VACSP study. The most useful infor-
mation that can be derived from this trial is that the
number of patients who would need to undergo
carotid endarterectomy (NNT) to prevent one peri-
operative death, ipsilateral stroke, or ipsilateral
crescendo TIA at 1 year is eight. The study was
stopped early with the release of the NASCET
results, there were few outcomes (seven events in the
91 surgical patients and 19 in the 98 patients
assigned to no surgery), and most of these were
crescendo TIAs rather than the more serious events
of major disability from stroke or death reported
elsewhere.
Functional status outcomes. NASCET41 pro-
vided a detailed account of disability in the two
groups. A previously validated functional status score
capturing the domains of vision, language compre-
hension, speech fluency, swallowing, upper and lower
limb function, and the integrated functions of ability
Table III. Methodologic rigor and quality of reporting
ECST NASCET VACSP
Randomization 
Concealment adequate adequate not described
Clinician blinding no no no
Patient blinding no no no
Description of intervention not described partly described not described
Management of cointerventions nonprotocolized usual care protocolized recommendations protocolized treatment
Documentation of cointerventions described and similar described and similar inadequately described
Documentation of baseline demo- adequately reported and similar adequately reported and similar adequately reported and similar
graphics
Documentation of handling of cross- adequately described adequately described adequately described
overs and protocol violations
Follow-up (%) 99.8 100 95
Documentation of follow-up adequately described adequately described adequately described
Outcome assessment
Assessor blinded no no no
Independent review yes yes yes
Randomization (% S/C) RCT (60/40) RCT (50/50) RCT (50/50)
Crossovers 
Medical to surgical (%) 3.5 6.5 3
Surgical to medical (%) 3.4 0.5 1
Analysis ITT ITT ITT
Analysis of crossovers not censored censored at cross over censored at cross over
Follow-up period
Mean (years) 6.1 5 1
Minimum (months) 4 4 not reported
ECST, European Carotid Surgery Trial; NASCET, North American Symptomatic Carotid Endarterectomy Trial; VACSP, Veterans Affairs
Cooperative Studies Program; ITT, intention to treat; S, patients randomized to surgery; C, patients randomized to control group; RCT,
randomized controlled trials.
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to go shopping and to make visits outside one’s
home was used to evaluate patients at baseline and
over time. The participants’ scores were suggestive of
low levels of overall disability. The mean scores
diverged over time, with a statistically significant dif-
ference in favor of the surgical group. The NNT to
prevent one previously nondisabled person with 70%
to 99% symptomatic stenosis from having major dis-
ability in any category was 11 patients.
Perioperative outcomes. Serious complications
other than stroke were rare (1% to 2% myocardial
infarction). Postoperative wound infections occurred
in 3%, hematoma in 5%, and reversible nerve injury
in 5% to 7%.33,40,42 In the 30-day period after
surgery or in the corresponding period after ran-
domization for those in medical groups, the absolute
risk for major disability from stroke or death was 3%
(95% CI, 2.2% to 3.8%).
ECST reported a multivariate model for risk of
major stroke or death within 5 days of surgery. Female
sex (hazard ratio, 2.4) and older age (hazard ratio,
0.96 per year) were predictive of negative outcomes.
Risk in this period was highly dependent on degree of
stenosis in a manner determined by a complex func-
tion. The NASCET study of patients with 30% to 70%
stenosis40 reported the following univariate risk fac-
tors and relative risks for perioperative strokes or
death: contralateral carotid occlusion, 2.3 (95% CI,
1.1 to 5.1); left carotid disease, 2.3 (95% CI, 1.4 to
3.8); the administration of less than 650 mg of
aspirin, 2.3 (95% CI, 1.3 to 3.8); ipsilateral ischemic
lesion on computed tomography (CT) or magnetic
resonance imaging, 2.0 (95% CI, 1.2 to 3.1); history
of diabetes, 2.0 (95% CI, 1.2 to 3.1); and diastolic
blood pressure of more than 90 mm Hg, 2.0 (95%
CI, 1.1 to 3.3). Other risks, including age, sex, and
Fig 1. Relative risk reductions and 95% confidence intervals for carotid endarterectomy as
compared with medical management in each of the three stenosis categories.
Table IV. Effectiveness of surgery by degree of stenosis
Relative risk reduction Absolute risk reduction Number needed to treat
Stenosis or increase, % (95% CI) or increase, % (95% CI) or harm (95% CI)
70% to 99% RRR 48 (27 to 63) ARR 6.7 (3.2 to 10) NNT 15 (10 to 31)
50% to 69% RRR 27 (5 to 44) ARR 4.7 (0.8 to 8.7) NNT 21 (11 to 125)
<49% RRI 20 (0 to 44) ARI 2.2 (0 to 4.4) NNH 45 (22 to ∝)
RRR, Relative risk reduction; ARR, absolute risk reduction; NNT, number needed to treat; RRI, relative risk increase; ARI, absolute
risk increase; NNH, number needed to harm.
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degree of stenosis, were not statistically significant as
predictors of perioperative risk in this study.
Age, sex, and degree of stenosis. The most
recent ECST report31 provides graphs that illustrate
the predictions of the multivariate model for benefit
in men and women of different ages and degree of
stenosis. Older age, male sex, and increasing degree
of stenosis and male sex were associated with greater
benefit of surgery.
In the NASCET 70% to 99% stenosis trial,
advanced age (>70 years) and male sex were among
the medical risk factors associated with increased
benefit. Increasing degrees of stenosis (70% to 79%,
80% to 89%, 90% to 99%) were associated with
increasing ARRs (12%, 18%, and 27%, respectively)
and decreasing NNTs (8, 5, and 4, respectively).15
In the NASCET 30% to 69% stenosis trial, male sex
was associated with increased benefit. For example,
in patients with 50% to 69% stenosis, the NNT to
prevent one disabling stroke was 16 for men and
125 for women. Age and increasing degree of steno-
sis was not associated with increased benefit in this
study.
Medical risk factors. NASCET10 prospectively
defined 15 medical risk factors. These were used to
subdivide the patient population into three groups
of approximately equal size. The presence of a
greater number of risk factors was associated with a
greater ARR. The groups of 0-5, 6, and 7 or greater
risk factors had ARRs (NNTs) for ipsilateral stroke at
2 years of 8% (13), 14% (7), and 30% (3), respec-
tively (Table V). The NASCET report for the 30% to
69% stenosis subgroups takes a different approach.
Recent stroke, recent hemispheric symptoms, and
the administration of 650 mg or more of aspirin per
day were each associated with increased benefit in a
multivariate analysis. For example, for patients with
50% to69% stenosis, the NNT to prevent one dis-
abling stroke was 13 for patients with a recent stroke
as compared with 59 in patients with TIAs only and
14 for patients administered 650mg or more of
aspirin daily as compared with 44 for those adminis-
tered less aspirin or no aspirin. It is important to
note that the factors identified are derived from
observational data and may be misleading if used to
guide intervention decisions. For example, random-
ized allocation of patients to different doses of
aspirin might give different results than those pre-
dicted from the observations in these trials in which
aspirin dose was determined by clinical habit and cir-
cumstances.
Hemispheric versus retinal events. Data
from patients in NASCET with 70% to 99% steno-
sis28 documented a lower risk of stroke in patients
whose first ever neurologic event (distinct from
qualifying event) had been retinal (59 patients)
rather than hemispheric TIA (70 patients). A con-
sistent effect was noted in the NASCET study of
patients with 30% to 70% stenosis. For example, in
patients with 50% to 69% stenosis, the NNT for
patients with recent hemispheric symptoms is 16,
compared with a negative impact on those with
retinal symptoms only.
Angiographic evidence of plaque ulceration.
In patients in NASCET with 70% to 99% stenosis,
429 had stenosis that presented a nonulcerated
appearance, and angiograms from the remaining
230 patients were identified as showing ulcerated
plaques. The effect of plaque ulceration and of the
degree of stenosis on the ability to benefit from
surgery seems to be quite complex.19 Firstly, in
patients without plaque ulceration, the gradient
Table V. Two-year risks for ipsilateral stroke and
effectiveness of surgery, according to number of
medical risk factors
Absolute risk, Absolute risk,
Number of nonsurgical surgical
risk factors patients (%) patients (%) ARR (%) NNT
0 to 5 17 9 8 12.5
6 23 9 14 7
≥7 39 9 30 3.3
ARR, Absolute risk reduction; NNT, number needed to treat.
Medical risk factors were: age, >70 years; male sex; smoking; dia-
betes; hyperlipidemia; hypertension; systolic blood pressure,
>160 mm Hg; diastolic blood pressure, >90 mm Hg; stroke with-
in 30 days; myocardial infarction; congestive heart failure; inter-
mittent claudication; and plaque ulceration.
Table VI. Effects of plaque ulceration and ipsilat-
eral stenosis on benefits of surgery, expressed as
absolute risk reduction (ARR) and number needed
to treat (NNT), for the outcome of any stroke or
death at 2 years19
Nonulcerated (n = 429) Ulcerated (n = 230)
Stenosis ARR NNT ARR NNT
75% (n = 270) 11.8 8.5 24.4 4.1
85% (n = 237) 10.7 9.3 37.1 2.7
95% (n = 152) 9.7 10 56.3 1.8
effect of increasing stenosis, discussed previously,
was no longer observed with ARRs of around 11%
(and NNT of 9) for any stroke or death at 2 years
(Table VI). Surgery was equally effective at all
degrees of stenosis. Secondly, surgery was more
effective in patients with ulceration than in those
without. Thirdly, in the group with plaque ulcera-
tion, a gradient effect of degree of stenosis on ARR
was still apparent.19
These data are derived from a Cox proportional
hazards model that estimates the risk associated with
various combinations of levels of ulceration, degree
of stenosis, and intervention (surgery vs no surgery).
It is these fitted estimates, rather than actual patient
events in each subgroup, that we have used to calcu-
late ARRs and NNTs. The absolute risk reduction
reflects both the underlying effectiveness of the treat-
ment (RRR) and the control event rate. The ARR in
patients with ulcerated lesions is greater than that in
patients without ulceration because both the RRR
and the control event rate are higher in patients with
ulceration than in those without. In the absence of
ulceration, the ARR is consistent across different
degrees of stenosis because neither the control event
rate nor the RRR differs. In the presence of ulcera-
tion, the increasing ARR with degree of stenosis is
the result of the higher event rates observed with
progressively higher degrees of stenosis because the
RRR does not change.
Previous recurrent events. The data from
NASCET26 were analyzed to determine whether the
presence of recurrent events over a prolonged period
of time (up to 12 months from the qualifying event)
modified the risk of stroke in the control group or the
ability to benefit from surgery. Patients with no events
before their qualifying event (161 patients) and
patients whose previous events had all occurred with-
in the 6 months before the qualifying event (283
patients) were analyzed together as patients with
problems of recent onset. These patients had an ARR
of 11% (NNT of 9). The patients who had events in
both the 0 to 6 months period and in the 7 to 12
months period before the qualifying event (ie, those
with longstanding recurrent events; 164 patients) had
an ARR of 30% (NNT of 3). These differences were
the result of the higher baseline risk of stroke and the
greater RRR in the latter group of patients.
Near occlusion of the carotid artery. It has been
hypothesized that patients with near occlusion of the
symptomatic carotid artery (ie, very severe stenosis,
delayed flow of angiographic material, and reduced
distal arterial calibre) have a different prognosis and
response to surgery than patients with other degrees of
stenosis. A subgroup analysis from NASCET23 found
no statistically significant differences across categories
for either perioperative events or 1-year risk of ipsilat-
eral stroke. Because there were only four perioperative
events and 12 events by 1 year in the 106 patients in
the near occlusion categories, the power of this obser-
vation is limited.
Contralateral carotid disease. In NASCET,20
43 patients (7%) had an occluded contralateral
carotid artery and 57 patients (9%) had contralateral
stenosis between 70% and 99%. The remainder had
degrees of stenosis between 0 and 69%. The benefits
of surgery in terms of the outcome “any stroke or
death” at 2 years were greater in the group with con-
tralateral occlusion (ARR, 45%; NNT, 2), but not in
the group with contralateral high grade stenosis
(ARR, 20%; NNT, 5). Interestingly, the group with
an occluded contralateral carotid artery had a higher
incidence rate (52%) of ipsilateral plaque ulceration
than either of the other groups (34% and 35%,
respectively). If the effect of plaque ulceration on the
ability to benefit that was discussed previously was
real, then plaque ulceration might be an important
confounder in this analysis of the effect of contralat-
eral carotid occlusion.
Lacunar strokes. Pathologic study results have
suggested43 that the underlying process in lacunar
stroke may not be artery-to-artery embolism. If this is
the case, then patients randomized in these trials on
the basis of a lacunar qualifying event might be
expected to benefit less from the intervention than
others, perhaps having a response more in keeping
with asymptomatic carotid stenosis. A subgroup
analysis from the ECST of patients with all degrees of
stenosis divided the 626 patients with abnormal
tomographic scan results into those with lacunar and
those with nonlacunar infarction.29 For patients with
lacunes, surgery was associated with a relative risk
increase of 22% (95% CI, 51% RRR to 200% relative
risk increase), and patients with CT evidence of non-
lacunar infarction had a 64% RRR with surgery (95%
CI, 44% to 81% RRR). The statistical test for interac-
tion (ie, does lacunar as opposed to nonlacunar stroke
affect the ability to benefit from surgery?) is signifi-
cant at a P value of .025.
Delay to surgery in patients with stroke. A
subgroup analysis from NASCET of 203 patients
with hemispheric strokes before surgery examined
the question of whether delay between the onset of
a hemispheric stroke to the time of surgery affects
outcome.21 The patients who underwent surgery
were divided into an early group, who underwent
surgery within 30 days of stroke, and a late group,
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whose surgery occurred more that 30 days after
stroke. No difference was found between these two
groups. The incidence rate of strokes within 30 days
of randomization was 5% in the medical group (95%
CI, 0.6% to 16%), 5% in the early surgical group
(95% CI, 1.0% to 14%), and 5% in the delayed sur-
gical group (95% CI, 1.6% to 11%). Life-table analy-
sis of the two surgical groups failed to show a differ-
ence at 18 months. No comparison with the medical
group was provided. The results were apparently
similar when the data were dichotomized at 14 or 21
days, rather than at 30 days.
Delay between stroke and randomization is likely
to reflect the referring physician’s concern for a pos-
sible increase in complications, in particular hemor-
rhagic transformation, when surgery is performed
early after stroke. Careful selection of cases for early
surgery would minimize differences between groups.
Indirect evidence of such selection bias is provided by
the difference in CT scan abnormalities between the
two groups (41% in early and 64% in delayed). In
addition, the patients in the late group differed from
those in the early group in that more than a month
had elapsed since their stroke without the occurrence
of a further severe neurologic event (which would
have led to their exclusion from the study) and with-
out death. This “survivorship” bias would operate in
the direction opposite to that of selection bias (ie,
producing better outcomes in the late group, where
no true difference exists). In addition to these prob-
lems, the sample size is small (only 42 patients under-
went carotid endarterectomy before 30 days and
fewer than 25 before 14 days) and the event rate low.
DISCUSSION
Both ECST and NASCET identified clinically and
statistically significant differences between groups for
all reported outcome clusters. We focused on the out-
come “death or disability” because this seemed the
most clinically relevant in stroke prevention. The
results of the meta-analysis document benefit for
patients with symptomatic stenosis of ≥50%.
Although there are caveats in the application of
the results of subgroup analysis to clinical practice,
consideration of a few epidemiologic principles sug-
gests which results are sufficiently strongly support-
ed to be of use in clinical practice and which would
be better regarded as hypothesis-generating only.
Refining indications for carotid endarterecto-
my. The degree of carotid stenosis is the most impor-
tant parameter in the balance of risk and benefit of
surgery. The pooled NNT is around 15 for patients
with 70% to 99% stenosis and around 21 for patients
with 50% to 69% stenosis, and, for <50% stenosis, the
operation is associated with harm. Within these broad
categories, both NASCET40 and ESCT31 observed a
gradient effect of benefit with increasing degree of
stenosis. Therefore, particularly for those patients with
50% to 69% stenosis, consideration of other variables,
along with (as for all patients) attention to periopera-
tive risk factors and the patient’s preferences, may
modify the decision as to whether to recommend
surgery or continued medical management.
In both studies, male sex and older age were
associated with increased benefit from surgery. The
consistency of these clinically and statistically signif-
icant results across studies, the gradient effect noted
with age in the ECST analysis, and the biologic plau-
sibility of greater benefit for men (because larger
artery size is associated with technically less chal-
lenging surgery) suggest that these are observations
that may be applied to clinical practice.
Increasing numbers of medical risk factors were
associated with increased effectiveness of surgery in
the NASCET study of patients with 70% to 99%
stenosis.10 None of the subgroups contained only a
few patients, the hypothesis was clearly specified a
priori, a gradient effect of clinically meaningful mag-
nitude was detected with increasing number of risk
factors, and the effect was biologically plausible in
that those with greatest baseline risk had greatest
benefit from an intervention, which seems to reduce
risk in all groups to a similar lower level (Table V).
This suggests that, in the consideration of patients’
preoperative vascular risk profiles, a balance must be
maintained between the exclusion of those whose
surgical risks are most profound and the inclusion of
those whose concomitant vascular risk factors
increase their ability to benefit from the intervention.
The original observation in patients with 70% to
99% stenosis—that patients with hemispheric events
benefit more from surgery than those whose events
were confined to the retina—was subsequently con-
firmed in the independent data set of patients with
30% to 69% stenosis. This, and the magnitude and
statistical significance of the effect, suggest that this
evidence is sufficiently strong to be of clinical use.
The presence of stroke (as opposed to TIA) was
a powerful modifier of ability to benefit in the for-
mer data set, and stroke was among the medical risk
factors that were found to be important predictors
of benefit in the latter study. Also of interest is the
analysis related to the degree of stenosis and the
presence of plaque ulceration. This study has bal-
anced distribution of patients across subgroups and
a large and statistically significant effect size. The
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idea that plaque ulceration is a modifier of the abili-
ty to benefit from surgery is interesting and biolog-
ically plausible, although it is worth noting that the
correlation between angiographic and intraoperative
findings is imperfect.44 The observation that
patients with longer histories of recurrent ischemic
events have a greater ability to benefit than those
whose ischemic events are more recent in onset is
consistent with the concept that more medical risk
factors and worse angiographic features (stenosis,
ulceration) are associated with greater ARRs with
surgery. However, because each of these results
derives from one analysis only, we would regard each
of these conclusions as lacking sufficiently strong
support to warrant incorporation in clinical decision
making and we would await the results of similar
subgroup analyses from ECST with interest.
Even less strongly supported are analyses of the
effects of lacunar strokes, near occlusion, contralat-
eral carotid stenosis and occlusion, or early surgery
after stroke. Subgroup membership is small, events
are few, and confirmation in an independent data set
is lacking. Regarding near occlusion, the data offer
no support either for those investigators who have
advocated emergency surgery for this condition or
for those who have cautioned that complications of
carotid endarterectomy are higher in this group.
The only conclusion that can be drawn from the
analysis of early surgery is that, in carefully selected
cases, early surgery after hemispheric stroke is not
associated with high risk.
Generalizability. In each of these studies, the
patients were randomized only after angiography had
documented the degree of stenosis. Since 1990, four
prospective studies45 have addressed the question of
risk of angiography in patients with symptomatic cere-
brovascular disease. The pooled risk of permanent
neurologic deficit or death obtained from these stud-
ies was 1.1% (95% CI, 0.6 to 2.0). It is difficult to
know how these complication rates might have
changed with the increasing use of intra-arterial digital
subtraction angiography and the increasing tendency
to perform carotid studies without selective carotid
catheterization because no data are available for
angiography performed in this way in patients with
cerebrovascular disease. Certainly, patients should not
undergo angiography until it has been determined that
they are suitable surgical candidates in all other
respects. When patients with stenosis >30% as deter-
mined with ultrasound scanning underwent angiogra-
phy, only 45% had stenosis in the 70% to 99% range.46
Therefore, more patients will be exposed to the risks of
angiography than can benefit from surgery. In the con-
sideration of whether a patient with a recent neuro-
logic event might benefit from carotid endarterecto-
my, physicians should take into account the risk of
stroke and death with angiography.
A further caveat is the low rate of perioperative
stroke and death observed in these studies: the over-
all results are sensitive to an increase in early postop-
erative events. It is therefore important that centers
that provide care for these patients prospectively
monitor their complication rates.
The exclusion criteria of NASCET and the use of
the uncertainty principle in ECST led to the selec-
tion for study of a group of patients with lower level
of cardiac morbidity than observed in cross-section-
al studies of patients with symptomatic carotid
stenosis.47 Because of these considerations, patients
able to benefit from carotid endarterectomy may be
a small proportion of those with clinical symptoms
suggestive of carotid territory ischemia. VACSP
screened 5000 patients (the method of screening
patients was not described) to identify 252 poten-
tially eligible patients (5%). Similar data are not avail-
able for the NASCET and ECST studies. Benefits
would be diluted were the results of these trials
applied indiscriminately to patients with higher peri-
operative risk.
CONCLUSION
Under the conditions that were achieved in the
trials, NASCET and ECST showed that carotid
endarterectomy led to a reduction in the subsequent
risk of death or major disability from stroke in
patients who were symptomatic with >50% ipsilateral
carotid stenosis. Particularly for patients whose
stenosis is at the lower end of this range, considera-
tion of age, sex, other medical risk factors, and the
presence of hemispheric rather than retinal ante-
cedent events may be used to modify the decision as
to whether to recommend carotid endarterectomy in
addition to continued medical management and risk-
factor modification.
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